Merck should be in the top 5. They did a deal with PH over at vla.
Like BristolMS they have a lot to lose if T cell therapies get bettered. They have 602 different clinical trials running or planned with Keytruda alone.
https://www.clinicaltrials.gov/ct2/results?term=keytruda&recrs=ab
Add to My Watchlist
What is My Watchlist?
